- Home
- FRAF vs PLX Comparison
FRAF vs PLX Comparison
Compare FRAF & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRAF
- PLX
- Stock Information
- Founded
- FRAF 1906
- PLX 1993
- Country
- FRAF United States
- PLX United States
- Employees
- FRAF N/A
- PLX N/A
- Industry
- FRAF Major Banks
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FRAF Finance
- PLX Health Care
- Exchange
- FRAF Nasdaq
- PLX Nasdaq
- Market Cap
- FRAF 152.9M
- PLX 122.6M
- IPO Year
- FRAF N/A
- PLX 1998
- Fundamental
- Price
- FRAF $36.76
- PLX $1.52
- Analyst Decision
- FRAF
- PLX Strong Buy
- Analyst Count
- FRAF 0
- PLX 1
- Target Price
- FRAF N/A
- PLX $15.00
- AVG Volume (30 Days)
- FRAF 48.9K
- PLX 1.2M
- Earning Date
- FRAF 07-22-2025
- PLX 08-13-2025
- Dividend Yield
- FRAF 3.60%
- PLX N/A
- EPS Growth
- FRAF N/A
- PLX N/A
- EPS
- FRAF 2.62
- PLX 0.05
- Revenue
- FRAF $71,310,000.00
- PLX $59,764,000.00
- Revenue This Year
- FRAF N/A
- PLX $65.02
- Revenue Next Year
- FRAF N/A
- PLX $57.34
- P/E Ratio
- FRAF $13.97
- PLX $31.46
- Revenue Growth
- FRAF 5.61
- PLX 0.18
- 52 Week Low
- FRAF $27.00
- PLX $0.82
- 52 Week High
- FRAF $40.76
- PLX $3.10
- Technical
- Relative Strength Index (RSI)
- FRAF 58.64
- PLX 45.63
- Support Level
- FRAF $33.87
- PLX $1.32
- Resistance Level
- FRAF $35.42
- PLX $1.67
- Average True Range (ATR)
- FRAF 0.96
- PLX 0.11
- MACD
- FRAF 0.26
- PLX 0.04
- Stochastic Oscillator
- FRAF 94.72
- PLX 55.71
About FRAF Franklin Financial Services Corporation
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.